Evolvence India Fund to exit Neuland Labs; puts entire stake of 33% on sale
Summary
Evolvence India Life Sciences Fund has put on the block its entire stake of around 33% in the holding company of listed pharmaceuticals firm Neuland Laboratories. The Evolvence fund invested $8.4 million in Neuland Health Sciences Pvt. Ltd. in December 2012. InvAscent, the advisor to the Evolvence India fund, is looking at selling the stake to buyout funds or strategic investors.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected